NBN and precursor B-cell acute lymphoblastic leukemia: To address these challenges, we comprehensively screened for germline NBN variants in a large cohort of 4,183 pediatric B-ALL patients, experimentally characterized these variants using two phenotyping assays, and evaluated their association with B-ALL characteristics and treatment outcomes.